Concepedia

Author

Douglas E. Horsman

BC Cancer Agency

Also Known As

D E Horsman, D HORSMAN, D Horsman, D. E. Horsman, D. Horsman, D.E Horsman, D.E. Horsman, Douglas E Horsman, Douglas E. Horsman, Douglas Edwin Horsman

155

Publications

12.1K

Citations

51

H-Index

77

Concepts

All Affiliations

BC Cancer AgencyUniversity of British ColumbiaVancouver General HospitalVancouver Hospital and Health Sciences CentreLeukemia & Lymphoma Society of Canada
DE

About

Douglas E. Horsman is an author at BC Cancer Agency specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

48

4.4K

2

Health Sciences

9

9

574

3

Cell Biology

9

9

1.3K

4

Allergy

1

1

28

5

Biostatistics

1

1

11

Douglas E. Horsman

×

93

Publications

11.4K

Citations

48

H-Index

YearCitations

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Ryan D. Morin, María Méndez-Lago, Andrew J. Mungall,

Nature

2011

1.6K

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

Kerry J. Savage, Nathalie A. Johnson, Susana Ben‐Neriah,

Blood

2009

663

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

Christian Steidl, Sohrab P. Shah, Bruce W. Woolcock,

Nature

2011

603

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

Nathalie A. Johnson, Kerry J. Savage, Olga Ludkovski,

Blood

2009

579

A Comprehensive Analysis of Common Copy-Number Variations in the Human Genome

Kendy K. Y. Wong, Ronald J. deLeeuw, Nirpjit S. Dosanjh,

The American Journal of Human Genetics

2006

521

Mantle Cell Lymphoma: A Clinicopathologic Study of 80 Cases

Larry H. Argatoff, Joseph M. Connors, Richard Klasa,

Blood

1997

500

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

Randy D. Gascoyne, Sheryle A. Adomat, Stanisław Krajewski,

Blood

1997

498

<i>BCL2</i> Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

Javeed Iqbal, Vishala T. Neppalli, George W. Wright,

Journal of Clinical Oncology

2006

303

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Javeed Iqbal, Warren G. Sanger, Douglas E. Horsman,

American Journal Of Pathology

2004

279

Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma

Valerie A. White, Jeffrey D. Chambers, Paul Courtright,

Cancer

1998

250

Page 1